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AIM: To analyse and assess common types of ADRs induced by anti-TB drugs in the 
study population by studying the adverse drug reactions, common ADRs, common 
drugs accounting for ADRs, systems involvement, causality and severity. In addition to 
identifying the risk factors and predictors associated with ADRs induced by anti-TB 
drugs in the study population, it is also to observe the management of the ADRs in the 
study population. METHODS: A retrospective observational record review study 
performed in Hospital Sg. Buloh, Selangor. 160 clinically diagnosed TB in-patients 
and/or out-patients who visited the Infectious Disease Unit in Hospital Sg. Buloh who                       
received the anti- tuberculosis regimen according to the protocol for TB treatment were 
included. Patient’s data were accessed retrospectively through electronic medical 
records. Descriptive data were analysed using frequency and percentage. Simple 
logistic regression was used for univariate analyses. Factors with significant p value 
were analysed using multiple logistic regression. RESULTS: A third of patients 
experienced ADR with half of the sample experiencing ADRs in short period of time 
(within the first 14 days). Half of our sample subjects had a “possible” causal reactions 
whereby two thirds of those suffering from an ADR had a severe reaction. Seven factors 
were identified as possible predictors which include age of between 41 to 50 years           
(p =. 041), 51 to 60 years (p =.101), female gender (p =.234), Malay ethnicity (p =.242), 
drug allergy (p =.225), pulmonary-TB (p =.160), intensive phase regime with                     
HREZ (p =.027) and maintenance phase regime with HR (p =.020). Final analysis with 
multiple logistic regression however shown factors included were not significantly 
associated with ADRs. CONCLUSION: The data obtained from this study has helped 
to uncover the statistical characteristics and estimate the burden in dealing with ADRs 
with anti-TB in Hospital Sg. Buloh. The possible risk factors that contributed to adverse 
drug reactions with anti-TB drugs in our sample were identified and therefore would 
facilitate physicians to screen and make prompt diagnosis of these ADRs, provide early 
management and counselling which will improve the outcomes of TB treatment.
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